USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND PEGASPARGASE

USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND PEGASPARGASE

The present invention provides use of mitoxantrone hydrochloride liposome and pegaspargase in preparation of drug for treating NK/T-cell lymphoma (NKTCL). The NKTCL comprises initial-treating, relapsed, and refractory extranodal NKTCL. Preferably, the initial-treating, relapsed, and refractory extra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YANG, Shasha, YAN, Shujie, WANG, Shixia, LI, Chunlei, LIN, Hongmei, ZHOU, Meng, XIA, Xuefang, LI, Yanhui
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YANG, Shasha
YAN, Shujie
WANG, Shixia
LI, Chunlei
LIN, Hongmei
ZHOU, Meng
XIA, Xuefang
LI, Yanhui
description The present invention provides use of mitoxantrone hydrochloride liposome and pegaspargase in preparation of drug for treating NK/T-cell lymphoma (NKTCL). The NKTCL comprises initial-treating, relapsed, and refractory extranodal NKTCL. Preferably, the initial-treating, relapsed, and refractory extranodal NKTCL is initial-treating, relapsed, and refractory extranodal nasal NKTCL. On this basis, other first-line and second-line drugs for treating NKTCL can also be further used. The present invention further provides a method for treating NKTCL. The method relates to administering therapeutically effective amounts of mitoxantrone hydrochloride liposome and pegaspargase to a patient. The mitoxantrone hydrochloride liposome improves the curative effect of pegaspargase on NKTCL, has little toxic and side effects, and increases the complete response rate (CR rate) and the partial response rate (PR rate) of diseases.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4180055A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4180055A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4180055A13</originalsourceid><addsrcrecordid>eNrjZLAODXZV8HdT8PUM8Y9w9AsJ8vdzVfCIdAnyd_bw8Q_ydHFV8PEM8A_293VVcPRzUQhwdXcMDnAMApKuPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7Uk3jXAxNDCwMDU1NHQmAglAK2CKSA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND PEGASPARGASE</title><source>esp@cenet</source><creator>YANG, Shasha ; YAN, Shujie ; WANG, Shixia ; LI, Chunlei ; LIN, Hongmei ; ZHOU, Meng ; XIA, Xuefang ; LI, Yanhui</creator><creatorcontrib>YANG, Shasha ; YAN, Shujie ; WANG, Shixia ; LI, Chunlei ; LIN, Hongmei ; ZHOU, Meng ; XIA, Xuefang ; LI, Yanhui</creatorcontrib><description>The present invention provides use of mitoxantrone hydrochloride liposome and pegaspargase in preparation of drug for treating NK/T-cell lymphoma (NKTCL). The NKTCL comprises initial-treating, relapsed, and refractory extranodal NKTCL. Preferably, the initial-treating, relapsed, and refractory extranodal NKTCL is initial-treating, relapsed, and refractory extranodal nasal NKTCL. On this basis, other first-line and second-line drugs for treating NKTCL can also be further used. The present invention further provides a method for treating NKTCL. The method relates to administering therapeutically effective amounts of mitoxantrone hydrochloride liposome and pegaspargase to a patient. The mitoxantrone hydrochloride liposome improves the curative effect of pegaspargase on NKTCL, has little toxic and side effects, and increases the complete response rate (CR rate) and the partial response rate (PR rate) of diseases.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230517&amp;DB=EPODOC&amp;CC=EP&amp;NR=4180055A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230517&amp;DB=EPODOC&amp;CC=EP&amp;NR=4180055A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YANG, Shasha</creatorcontrib><creatorcontrib>YAN, Shujie</creatorcontrib><creatorcontrib>WANG, Shixia</creatorcontrib><creatorcontrib>LI, Chunlei</creatorcontrib><creatorcontrib>LIN, Hongmei</creatorcontrib><creatorcontrib>ZHOU, Meng</creatorcontrib><creatorcontrib>XIA, Xuefang</creatorcontrib><creatorcontrib>LI, Yanhui</creatorcontrib><title>USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND PEGASPARGASE</title><description>The present invention provides use of mitoxantrone hydrochloride liposome and pegaspargase in preparation of drug for treating NK/T-cell lymphoma (NKTCL). The NKTCL comprises initial-treating, relapsed, and refractory extranodal NKTCL. Preferably, the initial-treating, relapsed, and refractory extranodal NKTCL is initial-treating, relapsed, and refractory extranodal nasal NKTCL. On this basis, other first-line and second-line drugs for treating NKTCL can also be further used. The present invention further provides a method for treating NKTCL. The method relates to administering therapeutically effective amounts of mitoxantrone hydrochloride liposome and pegaspargase to a patient. The mitoxantrone hydrochloride liposome improves the curative effect of pegaspargase on NKTCL, has little toxic and side effects, and increases the complete response rate (CR rate) and the partial response rate (PR rate) of diseases.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAODXZV8HdT8PUM8Y9w9AsJ8vdzVfCIdAnyd_bw8Q_ydHFV8PEM8A_293VVcPRzUQhwdXcMDnAMApKuPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7Uk3jXAxNDCwMDU1NHQmAglAK2CKSA</recordid><startdate>20230517</startdate><enddate>20230517</enddate><creator>YANG, Shasha</creator><creator>YAN, Shujie</creator><creator>WANG, Shixia</creator><creator>LI, Chunlei</creator><creator>LIN, Hongmei</creator><creator>ZHOU, Meng</creator><creator>XIA, Xuefang</creator><creator>LI, Yanhui</creator><scope>EVB</scope></search><sort><creationdate>20230517</creationdate><title>USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND PEGASPARGASE</title><author>YANG, Shasha ; YAN, Shujie ; WANG, Shixia ; LI, Chunlei ; LIN, Hongmei ; ZHOU, Meng ; XIA, Xuefang ; LI, Yanhui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4180055A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YANG, Shasha</creatorcontrib><creatorcontrib>YAN, Shujie</creatorcontrib><creatorcontrib>WANG, Shixia</creatorcontrib><creatorcontrib>LI, Chunlei</creatorcontrib><creatorcontrib>LIN, Hongmei</creatorcontrib><creatorcontrib>ZHOU, Meng</creatorcontrib><creatorcontrib>XIA, Xuefang</creatorcontrib><creatorcontrib>LI, Yanhui</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YANG, Shasha</au><au>YAN, Shujie</au><au>WANG, Shixia</au><au>LI, Chunlei</au><au>LIN, Hongmei</au><au>ZHOU, Meng</au><au>XIA, Xuefang</au><au>LI, Yanhui</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND PEGASPARGASE</title><date>2023-05-17</date><risdate>2023</risdate><abstract>The present invention provides use of mitoxantrone hydrochloride liposome and pegaspargase in preparation of drug for treating NK/T-cell lymphoma (NKTCL). The NKTCL comprises initial-treating, relapsed, and refractory extranodal NKTCL. Preferably, the initial-treating, relapsed, and refractory extranodal NKTCL is initial-treating, relapsed, and refractory extranodal nasal NKTCL. On this basis, other first-line and second-line drugs for treating NKTCL can also be further used. The present invention further provides a method for treating NKTCL. The method relates to administering therapeutically effective amounts of mitoxantrone hydrochloride liposome and pegaspargase to a patient. The mitoxantrone hydrochloride liposome improves the curative effect of pegaspargase on NKTCL, has little toxic and side effects, and increases the complete response rate (CR rate) and the partial response rate (PR rate) of diseases.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4180055A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND PEGASPARGASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T06%3A57%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YANG,%20Shasha&rft.date=2023-05-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4180055A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true